| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $90K | +143.2% |
| SG&A Expense | $5.2M | +373.3% |
| Operating Income | -$5.3M | -337.5% |
| Net Income | -$535K | -234.2% |
| EPS (Basic) | -$0.01 | +92.3% |
| EPS (Diluted) | -$0.09 | +30.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.2M | +1122.8% |
| Current Assets | $5.7M | +786.6% |
| Total Assets | $7.2M | -94.7% |
| Current Liabilities | $1.8M | +330.9% |
| Total Liabilities | $7.7M | +52.2% |
| Stockholders' Equity | -$457K | +89.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.7M | -489.1% |
| Investing Cash Flow | $725K | +100.5% |
| Financing Cash Flow | $10.9M | -92.0% |